Global Nucleic Acid Delivery System Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Nucleic Acid Delivery System Market Insights, Forecast to 2034
Nucleic Acid Delivery System (NADS) refers to a range of technologies and methods that are used to deliver nucleic acids, such as DNA or RNA, into cells or tissues. In gene therapy and genetic engineering, NADS play a critical role in delivering therapeutic genes to target cells to treat genetic diseases, as well as in introducing new genetic traits into organisms for various purposes.
The delivery of nucleic acids into cells is challenging due to their large size, negative charge, and susceptibility to degradation by nucleases in the extracellular environment. NADS typically consist of a carrier molecule, such as a lipid or polymer, which can protect the nucleic acids and facilitate their entry into cells. Different types of NADS have been developed over the years, including viral vectors, non-viral vectors, and physical methods such as electroporation and sonoporation.
NADS have become increasingly important in biomedical research and clinical applications, and have shown promising results in treating a variety of genetic diseases, including cystic fibrosis, hemophilia, and muscular dystrophy. They also hold promise for the development of new therapies for cancer and other complex diseases.
Market Analysis and InsightsGlobal Nucleic Acid Delivery System Market
Global Nucleic Acid Delivery System market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Nucleic Acid Delivery System industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Nucleic Acid Delivery System key companies include Creative Biogene, Evonik Health Care, Factor Bioscience, Polyplus and AccuRna, etc. Creative Biogene, Evonik Health Care, Factor Bioscience are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Nucleic Acid Delivery System were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Nucleic Acid Delivery System market and estimated to attract more attentions from industry insiders and investors.
Nucleic Acid Delivery System can be divided into Viral Vectors, Lipid-based Carriers and Protein-based Carriers,, etc. Viral Vectors is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Nucleic Acid Delivery System is widely used in various fields, such as Drug Development, Gene Therapy, Biopharmaceuticals and Scientific Research, etc. Drug Development provides greatest supports to the Nucleic Acid Delivery System industry development. In 2022, global % revenue of Nucleic Acid Delivery System went into Drug Development filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Nucleic Acid Delivery System market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Nucleic Acid Delivery System market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Vector, Application and Regions Listed in the Report
Creative Biogene
Evonik Health Care
Factor Bioscience
Polyplus
AccuRna
Segment by Vector
Viral Vectors
Lipid-based Carriers
Protein-based Carriers
Drug Development
Gene Therapy
Biopharmaceuticals
Scientific Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, vector and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by vector from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by vector and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by vector and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by vector and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by vector and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by vector and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Nucleic Acid Delivery System introduction, etc. Nucleic Acid Delivery System Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Nucleic Acid Delivery System
Chapter 13Methodology and Data Sources adopted by MRAResearch
The delivery of nucleic acids into cells is challenging due to their large size, negative charge, and susceptibility to degradation by nucleases in the extracellular environment. NADS typically consist of a carrier molecule, such as a lipid or polymer, which can protect the nucleic acids and facilitate their entry into cells. Different types of NADS have been developed over the years, including viral vectors, non-viral vectors, and physical methods such as electroporation and sonoporation.
NADS have become increasingly important in biomedical research and clinical applications, and have shown promising results in treating a variety of genetic diseases, including cystic fibrosis, hemophilia, and muscular dystrophy. They also hold promise for the development of new therapies for cancer and other complex diseases.
Market Analysis and InsightsGlobal Nucleic Acid Delivery System Market
Global Nucleic Acid Delivery System market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Nucleic Acid Delivery System industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Nucleic Acid Delivery System key companies include Creative Biogene, Evonik Health Care, Factor Bioscience, Polyplus and AccuRna, etc. Creative Biogene, Evonik Health Care, Factor Bioscience are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Nucleic Acid Delivery System were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Nucleic Acid Delivery System market and estimated to attract more attentions from industry insiders and investors.
Nucleic Acid Delivery System can be divided into Viral Vectors, Lipid-based Carriers and Protein-based Carriers,, etc. Viral Vectors is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Nucleic Acid Delivery System is widely used in various fields, such as Drug Development, Gene Therapy, Biopharmaceuticals and Scientific Research, etc. Drug Development provides greatest supports to the Nucleic Acid Delivery System industry development. In 2022, global % revenue of Nucleic Acid Delivery System went into Drug Development filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Nucleic Acid Delivery System market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Nucleic Acid Delivery System market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Vector, Application and Regions Listed in the Report
By Company
Creative Biogene
Evonik Health Care
Factor Bioscience
Polyplus
AccuRna
Segment by Vector
Viral Vectors
Lipid-based Carriers
Protein-based Carriers
Segment by Application
Drug Development
Gene Therapy
Biopharmaceuticals
Scientific Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, vector and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by vector from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by vector and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by vector and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by vector and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by vector and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by vector and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Nucleic Acid Delivery System introduction, etc. Nucleic Acid Delivery System Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Nucleic Acid Delivery System
Chapter 13Methodology and Data Sources adopted by MRAResearch
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices